Skip to content

Effect of general anesthesia with ciprofol versus propofol on the quality of postoperative recovery in patients undergoing arthroscopic surgery

Effect of general anesthesia with ciprofol versus propofol on the quality of postoperative recovery in patients undergoing arthroscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082777
Enrollment
Unknown
Registered
2024-04-08
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing arthroscopic surgery under general anesthesia

Interventions

Ciprofol group:In the Ciprofol group, general anesthesia was induced using ciprofol 0.2-0.4 mg/kg and sufentanil 0.3-0.5 µg/kg intravenously. Anesthesia was maintained with ciprofol 0.8-1.5 mg/kg/h
Propofol group:In the propofol group, general anesthesia was induced with propofol 2-3 mg/kg and sufentanil 0.3-0.5µg/kg intravenously. Anesthesia was maintained with propofol 4-10mg/kg/h.

Sponsors

Lishui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-65 years, ASA class 1-2, with a body mass index (BMI) =18 and =30 kg/m2; all patients who underwent arthroscopic surgery under general anesthesia were recruited.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women and women who plan to give birth within 3 months (including male patients); 2. Obvious respiratory or circulatory dysfunction before surgery, obvious abnormalities in blood and biochemical indicators, serious neuropsychiatric disorders, endocrine system diseases, psychosomatic diseases, history of chronic analgesic or sedative drug use (including benzodiazepines), alcohol abuse, history of insomnia; 3. use of benzodiazepines or opioids within 1 month, contraindications to or allergic reactions to benzodiazepines, opioids, propofol, and their components; 4. those estimated to be difficult to intubate; 5. Patients who, in the judgment of the investigator, are not suitable for participation in this trial for any reason. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
QoR-15;

Secondary

MeasureTime frame
Quality of sleep;MAP;HR;SPO2;Time from administration to loss of consciousness;Loss of consciousness BIS;Dose required for the loss of consciousness;Time from sedative medication to BIS60;Dose of sedative drugs to BIS60;Intraoperative use of vasoactive drugs;Low blood pressure;Blood pressure fluctuations;Cumulative dose of ciprofol or propofol;Cumulative dose of sufentanil;Cumulative dose of cisatracurium;Minimum intraoperative MAP;Minimum intraoperative HR;Records related to surgical anesthesia;Time from discontinuation to recovery of spontaneous respiration;Time to recovery of consciousness from drug withdrawal;Discontinue medication until consciousness is restored BIS;Time of extubation;Recovery room occupancy time;Orientation recovery time;Sedative agitation SAS score at Extubation;Time of discharging from bed;Total length of stay;Patient Satisfaction Score;Postoperative delirium;

Countries

China

Contacts

Public ContactFaxing Wang

Lishui People's Hospital

faxingwanglive@163.com+86 189 5709 2002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026